Abstract
The cellular effects of aurumacryl (a drug based on gold polyacrylate, which previously showed significant antitumor activity in vivo against solid tumors in mice) were studied in the model of the MCF7 stable cell line of human breast carcinoma. It was found that aurumacryl possesses cytotoxic and cytostatic effects on tumor cells. The dose-dependent cytotoxic effect of aurumacryl is expressed as the death of 60% of tumor cells after incubation with aurumacryl at a dose of 1 mg/mL for 24 h. The proliferation kinetics of the surviving fraction of tumor cells also undergoes significant changes, which is expressed in the predominant accumulation of the cells (93%) in the G0 phase of proliferative rest and in a significant decrease in the number of proliferating cells to 7%. These data could be interpreted as evidence of the loss of the reproductive ability of the surviving cells after treatment with aurumacryl.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
D. B. Korman, Fundamentals of Antitumor Therapy (Prakticheckaya Meditsina, Moscow, 2006).
V. N. Babin, Yu. A. Belousov, V. I. Borisov, et al., Izv. Akad. Nauk, Ser. Khim. No. 11, 2405 (2014).
I. A. Efimenko, Koordinats. Khim. 24 (4), 282 (1998).
D. Saggioro, M. P Rigobello, L. Paloschi, et al., Chem. Biol. 14, 1128 (2007).
S. Nobili, E. Mini, I. Landini, et al., Med. Res. Rev. 30, 550 (2010).
A. Markowska, B. Kasprzak, K. Jaszczynska-Nowinka, et al., Contemp. Oncol. (Poznan) 19, 271 (2015).
M. G. Voronkov, K. A. Abzaeva, L. V. Zhilitskaya, et al., RF Patent No. 2372091 (May 20, 2008).
L. A. Ostrovskaya, M. G. Voronkov, D. B. Korman, et al., J. Cancer Ther. 1 (2), 59 (2010).
L. A. Ostrovskaya, D. B. Korman, N. V. Bluhterova, et al., Biointerface Res. Appl. Chem. 4 (4), 816 (2014).
L. A. Ostrovskaya, M. G. Voronkov, D. B. Korman, et al., Biophysics (Moscow) 59 (4), 642 (2014).
K. A. Abzaeva and L. E. Zelenkov, Izv. Akad. Nauk, Ser. Khim. No. 6, 1233 (2015). doi 10.1007/s11172-015-1006-3
L. T. Li, G. Jiang, Q. Chen, and J. N. Zheng, Mol. Med. Rep. 11 (3), 1566 (2015).
R. Pezzilli, S. Partelli, R. Cannizzaro, et al., Adv. Med. Sci. 61 (1), 147 (2016).
A. N. Osipov, A. Grekhova, M. Pustovalova, et al., Oncotarget 6 (29), 26876 (2015).
A. K. Grekhova, P. S. Eremin, A. N. Osipov, et al., Radiats. Biol. Radioekol. 55 (4), 395 (2015).
A. N. Osipov, M. Pustovalova, A. Grekhova, et al., Oncotarget 6 (29), 27275 (2015).
M. Lobrich, A. Shibata, A. Beucher, et al., Cell Cycle 9, 662 (2010).
A. Casini and L. Messori, Curr. Top. Med. Chem. 11, 2647 (2011).
P. I. Maria, V. M. Deflon, and U. Abram, Future Med. Chem. 6, 1515 (2014).
L. Ranconi, D. P. Aldinucoi, and D. Fregona, Anticancer Agents. Med. Chem. 10, 283 (2010).
N. A. Plate, Physiologically Active Polymers (Khimiya, Moscow, 1986) [in Russian].
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © L.A. Ostrovskaya, A.K. Grehova, D.B. Korman, A.N. Osipov, N.V. Bluhterova, M.M. Fomina, V.A. Rikova, K.A. Abzaeva, 2017, published in Biofizika, 2017, Vol. 62, No. 3, pp. 598–603.
Rights and permissions
About this article
Cite this article
Ostrovskaya, L.A., Grehova, A.K., Korman, D.B. et al. Cellular effects of the antitumor drug aurumacryl. BIOPHYSICS 62, 485–489 (2017). https://doi.org/10.1134/S0006350917030150
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006350917030150